The global preterm birth and premature rupture of membranes (PROM) testing market, valued at approximately USD 1.7 billion in 2021, is set to experience steady growth over the next decade. With a projected Compound Annual Growth Rate (CAGR) of 3.2%, the market is expected to reach an estimated valuation of nearly USD 2.5 billion by the end of 2032.
The increasing prevalence of preterm births, along with advancements in diagnostic technologies, is driving the demand for preterm birth and PROM testing. Accurate and timely testing plays a critical role in managing and preventing complications associated with premature births, ensuring better outcomes for both mothers and infants. As awareness and accessibility to prenatal care improve globally, the market is set for continued growth.
Why do ultrasound tests lead the market for PROM testing?
Once patients are diagnosed with PROM or preterm birth, period assessments are conducted. Studies have found that in the absence of other maternal or fetal factors, routine and frequent ultrasound examinations are an efficient way to manage PROM. The market through this test type witnessed a CAGR of 2.9% between 2017 and 2021 and is forecasted to gain a CAGR of 3.1%. The frequency of the conduction of these tests, their non-invasive nature, and their use combined with other diagnostic tests means that they lead the market for testing.
Competitive Landscape
Preterm Birth and PROM testing providers are focused on increasing the efficiency, accuracy, and affordability of their tests. The key companies operating in the market include Qiagen N.V., Cooper Surgical Inc., Hologic, Abbott, Biosynex, Medixbiochemica, Sera Prognostics, IQ Products, Creative Diagnostics, Nanjing Liming Biological Preparations Co., Ltd., Clinical Innovations, LLC, and Bioserv Diagnostic GmbH.
Some of the recent development in Preterm Birth and PROM testing are as follows:
- In September 2020, PregnanTech, an Israeli company announced the development of LIONESSTM, a device that aims to delay preterm birth. The product is a silicone ring that takes a few minutes to place and functions by remaining set in place to prevent dilatation and keep the cervix elongated. This system can help delay Preterm Births. The device is easily removable and disposable and has a self-release mechanism. The device is currently undergoing further clinical trials.
- In April 2018, Qiagen received FDA approval for its PartoSure test which assesses patients with preterm labor symptoms to determine possible spontaneous preterm birth risks.
Similarly, recent developments related to companies manufacturing Preterm Birth and PROM testing have been tracked by the team at Future Market Insights, which is available in the full report.
Key Segments Covered in Preterm Birth and PROM testing Survey
Preterm Birth and PROM testing Market by Type:
- Biochemical Markers
- Pelvic exam
- Ultrasound
- Uterine Monitoring
- Nitazine Test
- Ferning Test
- Pooling
- PAMG-1 Immunoassay
- IGFBP Test
- Fetal Fibronectin (fFN)
- Other Test Types
Preterm Birth and PROM testing Market by Region:
- North America Preterm Birth and PROM testing Market
- Latin America Preterm Birth and PROM testing Market
- Europe Preterm Birth and PROM testing Market
- Asia Pacific Preterm Birth and PROM testing Market
- Middle East & Africa Preterm Birth and PROM testing Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
